Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Breast Neoplasms × Lymph Node Excision × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Lymphatic Metastasis 1 Endometrial Neoplasms 1 Breast Neoplasms 1

Interventions

Fulvestrant 50 Trastuzumab 39 Letrozole 39 pembrolizumab 38 Capecitabine 36 ribociclib 34 abemaciclib 31 Cyclophosphamide 31 Carboplatin 30 Paclitaxel 29 Specimen Handling 28 Blood Specimen Collection 26 trastuzumab deruxtecan 25 pertuzumab 25 Surveys and Questionnaires 24 Docetaxel 23 Magnetic Resonance Spectroscopy 21 Biopsy 20 Anastrozole 20 Tamoxifen 19 palbociclib 18 Radiotherapy 18 130-nm albumin-bound paclitaxel 18 sacituzumab govitecan 17 exemestane 17 Injections 17 Neoadjuvant Therapy 16 olaparib 14 Exercise 14 Bevacizumab 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04889924 2026-03-12

ADARNAT

Hospital Universitari de Bellvitge

Phase NA Recruiting

Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡